首页 > 最新文献

Indian Journal of Palliative Care最新文献

英文 中文
Prolonged Indwelling Percutaneous Nephrostomy Leading to Purple Urinary Bag Syndrome in Palliative Care Setting: A Case Report. 姑息治疗环境中长期留置经皮肾造口术导致紫色尿袋综合征:一例报告。
IF 1.1 Q4 HEALTH CARE SCIENCES & SERVICES Pub Date : 2023-07-01 Epub Date: 2023-07-25 DOI: 10.25259/IJPC_162_2022
Divya Sai Vanumu, Shyam Prasad Mantha, Praneeth Suvvari, Praveen Kumar Kodisharapu

Purple urine bag syndrome (PUBS) is a complication and a rare phenomenon associated with bacterial colonisation in bladder catheters in which urine turns purple in the tubing and the catheter bag. This condition can be distressing and panicking for the patients and their families as well as the medical staff caring for them. It is an interesting and unusual presentation that affects people with long-term indwelling catheters and chronic constipation. We report one such case in our hospital, a 73-year-old woman with stage 4 cancer of the vaginal vault, post-bilateral percutaneous nephrostomy (PCN) 4 months ago, currently on best supportive care, presented to the emergency room with symptoms of urosepsis, while a purple urine bag may appear innocuous and not need any particular care beyond replacing the catheter and giving the patient the proper antibiotics, it may indicate an occult urinary tract infection (UTI), which can have catastrophic effects in a patient using a urinary catheter for an extended period of time. Only a few examples of PUBS with an underlying nephrostomy have been documented in the literature. This is a case of a palliative care patient who had a poor prognosis despite receiving the right antibiotic treatment for an upper UTI that caused purple staining of the PCN catheter bag. Using this case report as a guide, we could manage a complex UTI in a palliative care context.

紫色尿袋综合征(PUBS)是一种并发症,也是一种罕见的与膀胱导管中细菌定植有关的现象,其中尿液在导管和导管袋中变为紫色。这种情况可能会让患者及其家人以及照顾他们的医护人员感到痛苦和恐慌。这是一个有趣而不寻常的表现,影响了长期留置导管和慢性便秘的人。我们在我院报告了一例这样的病例,一名73岁的女性,阴道窦癌症4期,4个月前双侧经皮肾造瘘术(PCN)后,目前正在接受最好的支持性护理,因尿脓毒症症状出现在急诊室,虽然紫色尿袋可能看起来无害,除了更换导尿管和给患者服用适当的抗生素外,不需要任何特别的护理,但它可能表明存在隐性尿路感染(UTI),这可能会对长期使用导尿管的患者产生灾难性影响。文献中只记录了一些潜在肾造瘘的PUBS病例。这是一例姑息治疗患者,尽管对导致PCN导管袋紫色染色的上尿路感染进行了正确的抗生素治疗,但预后不佳。以这份病例报告为指导,我们可以在姑息治疗的背景下处理复杂的尿路感染。
{"title":"Prolonged Indwelling Percutaneous Nephrostomy Leading to Purple Urinary Bag Syndrome in Palliative Care Setting: A Case Report.","authors":"Divya Sai Vanumu,&nbsp;Shyam Prasad Mantha,&nbsp;Praneeth Suvvari,&nbsp;Praveen Kumar Kodisharapu","doi":"10.25259/IJPC_162_2022","DOIUrl":"10.25259/IJPC_162_2022","url":null,"abstract":"<p><p>Purple urine bag syndrome (PUBS) is a complication and a rare phenomenon associated with bacterial colonisation in bladder catheters in which urine turns purple in the tubing and the catheter bag. This condition can be distressing and panicking for the patients and their families as well as the medical staff caring for them. It is an interesting and unusual presentation that affects people with long-term indwelling catheters and chronic constipation. We report one such case in our hospital, a 73-year-old woman with stage 4 cancer of the vaginal vault, post-bilateral percutaneous nephrostomy (PCN) 4 months ago, currently on best supportive care, presented to the emergency room with symptoms of urosepsis, while a purple urine bag may appear innocuous and not need any particular care beyond replacing the catheter and giving the patient the proper antibiotics, it may indicate an occult urinary tract infection (UTI), which can have catastrophic effects in a patient using a urinary catheter for an extended period of time. Only a few examples of PUBS with an underlying nephrostomy have been documented in the literature. This is a case of a palliative care patient who had a poor prognosis despite receiving the right antibiotic treatment for an upper UTI that caused purple staining of the PCN catheter bag. Using this case report as a guide, we could manage a complex UTI in a palliative care context.</p>","PeriodicalId":13319,"journal":{"name":"Indian Journal of Palliative Care","volume":"29 3","pages":"324-327"},"PeriodicalIF":1.1,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/ea/28/IJPC-29-324.PMC10493687.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10239163","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Science to Spirituality in Paediatric Palliative Care: A Commentary. 儿科姑息治疗中的精神科学:述评。
IF 1.1 Q4 HEALTH CARE SCIENCES & SERVICES Pub Date : 2023-07-01 Epub Date: 2023-09-02 DOI: 10.25259/IJPC_48_2023
R R Pravin

Spirituality in paediatric palliative care remains an enigma across both the Eastern and Western worlds. There is no absolute science to it, and it can be a barrier to effective palliative care to be delivered. This article aims to discuss the barriers to and recommendations for discussing this sensitive topic with children and their families to enhance the quality of palliative care rendered, with the aid of case studies to illustrate the underestimated importance of spirituality in paediatric palliative care.

在东西方世界,儿科姑息治疗的精神仍然是一个谜。它没有绝对的科学依据,它可能是提供有效姑息治疗的障碍。本文旨在讨论与儿童及其家人讨论这一敏感话题的障碍和建议,以提高姑息治疗的质量,并借助案例研究来说明精神在儿科姑息治疗中被低估的重要性。
{"title":"The Science to Spirituality in Paediatric Palliative Care: A Commentary.","authors":"R R Pravin","doi":"10.25259/IJPC_48_2023","DOIUrl":"10.25259/IJPC_48_2023","url":null,"abstract":"<p><p>Spirituality in paediatric palliative care remains an enigma across both the Eastern and Western worlds. There is no absolute science to it, and it can be a barrier to effective palliative care to be delivered. This article aims to discuss the barriers to and recommendations for discussing this sensitive topic with children and their families to enhance the quality of palliative care rendered, with the aid of case studies to illustrate the underestimated importance of spirituality in paediatric palliative care.</p>","PeriodicalId":13319,"journal":{"name":"Indian Journal of Palliative Care","volume":"29 3","pages":"336-339"},"PeriodicalIF":1.1,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/78/9d/IJPC-29-336.PMC10493681.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10239167","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Development of Care Pathway for Assessment and Treatment of Fatigue in Palliative Care. 姑息治疗中疲劳评估和治疗护理途径的开发。
IF 1.1 Q4 HEALTH CARE SCIENCES & SERVICES Pub Date : 2023-07-01 Epub Date: 2023-01-11 DOI: 10.25259/IJPC_194_2022
Mochamat Mochamat, Marta Przyborek, Birgit Jaspers, Henning Cuhls, Rupert Conrad, Martin Mücke, Lukas Radbruch

Objectives: Fatigue is a frequent and burdensome symptom in patients with advanced disease in palliative care. However, it is under-assessed and undertreated in clinical practice, even though many treatment options have been identified in systematic reviews. Care pathways with defined and standardised steps have been recommended for effective management in the clinical setting. This paper describes a care pathway for managing fatigue in palliative care patients. This study aims to develop a care pathway with detailed guidance for screening, assessment, diagnosis, and treatment of fatigue in palliative care patients.

Material and methods: A collaborative effort of multidisciplinary clinicians participated in constructing the care pathway. The care pathway was developed using the following steps: (a) Developing an intervention; (b) piloting and feasibility; (c) evaluating the intervention; (d) reporting; and (e) implementation. This paper covers the first step, which includes the evidence base identification, theory identification/development, and process/outcomes modeling. A literature search was conducted to understand the extent of the fatigue problem in the palliative care setting and identify existing guidelines and strategies for managing fatigue. Consistent recommendations emanating from the included papers were then contributed to a care pathway. Patient representatives and palliative care professionals provided feedback on the draft.

Results: The care pathway address the following care processes: (1) Screening for the presence of fatigue; (2) assessment to evaluate the severity of fatigue; (3) diagnostic procedure, including history, physical examination, and laboratory finding; (4) therapeutic management pathway for clinical decision-making; and (5) valuation of treatment effect, using questionnaires, diaries and physical activity monitoring with body-worn sensors.

Conclusion: The development of a care pathway will help to implement regular and structured assessment, diagnosis, and treatment of fatigue for healthcare professionals treating palliative care patients. Reviewing the pathway with a multidisciplinary expert group and field testing the pathway will be the next steps toward implementation.

目的:在姑息治疗中,疲劳是晚期疾病患者常见且负担沉重的症状。然而,尽管在系统综述中已经确定了许多治疗方案,但在临床实践中,它的评估不足,治疗不足。建议采用具有明确和标准化步骤的护理途径,以便在临床环境中进行有效管理。本文描述了一种治疗姑息治疗患者疲劳的护理途径。本研究旨在开发一种护理途径,为姑息治疗患者的疲劳筛查、评估、诊断和治疗提供详细指导。材料和方法:多学科临床医生共同努力,参与构建护理路径。护理途径是通过以下步骤制定的:(a)制定干预措施;(b) 试点和可行性;(c) 评估干预措施;(d) 报告;以及(e)执行。本文涵盖了第一步,包括证据库识别、理论识别/开发和过程/结果建模。进行了文献检索,以了解姑息治疗环境中疲劳问题的严重程度,并确定现有的疲劳管理指南和策略。随后,纳入的论文中提出的一致建议被纳入护理途径。患者代表和姑息治疗专业人员对草案提供了反馈意见。结果:护理途径涉及以下护理过程:(1)筛查疲劳的存在;(2) 评估疲劳的严重程度;(3) 诊断程序,包括病史、体格检查和实验室发现;(4) 临床决策的治疗管理途径;以及(5)使用问卷、日记和佩戴传感器的身体活动监测来评估治疗效果。结论:护理途径的开发将有助于为治疗姑息治疗患者的医护人员实施定期和结构化的疲劳评估、诊断和治疗。与多学科专家组一起审查该途径,并对该途径进行实地测试,这将是实施的下一步。
{"title":"Development of Care Pathway for Assessment and Treatment of Fatigue in Palliative Care.","authors":"Mochamat Mochamat,&nbsp;Marta Przyborek,&nbsp;Birgit Jaspers,&nbsp;Henning Cuhls,&nbsp;Rupert Conrad,&nbsp;Martin Mücke,&nbsp;Lukas Radbruch","doi":"10.25259/IJPC_194_2022","DOIUrl":"10.25259/IJPC_194_2022","url":null,"abstract":"<p><strong>Objectives: </strong>Fatigue is a frequent and burdensome symptom in patients with advanced disease in palliative care. However, it is under-assessed and undertreated in clinical practice, even though many treatment options have been identified in systematic reviews. Care pathways with defined and standardised steps have been recommended for effective management in the clinical setting. This paper describes a care pathway for managing fatigue in palliative care patients. This study aims to develop a care pathway with detailed guidance for screening, assessment, diagnosis, and treatment of fatigue in palliative care patients.</p><p><strong>Material and methods: </strong>A collaborative effort of multidisciplinary clinicians participated in constructing the care pathway. The care pathway was developed using the following steps: (a) Developing an intervention; (b) piloting and feasibility; (c) evaluating the intervention; (d) reporting; and (e) implementation. This paper covers the first step, which includes the evidence base identification, theory identification/development, and process/outcomes modeling. A literature search was conducted to understand the extent of the fatigue problem in the palliative care setting and identify existing guidelines and strategies for managing fatigue. Consistent recommendations emanating from the included papers were then contributed to a care pathway. Patient representatives and palliative care professionals provided feedback on the draft.</p><p><strong>Results: </strong>The care pathway address the following care processes: (1) Screening for the presence of fatigue; (2) assessment to evaluate the severity of fatigue; (3) diagnostic procedure, including history, physical examination, and laboratory finding; (4) therapeutic management pathway for clinical decision-making; and (5) valuation of treatment effect, using questionnaires, diaries and physical activity monitoring with body-worn sensors.</p><p><strong>Conclusion: </strong>The development of a care pathway will help to implement regular and structured assessment, diagnosis, and treatment of fatigue for healthcare professionals treating palliative care patients. Reviewing the pathway with a multidisciplinary expert group and field testing the pathway will be the next steps toward implementation.</p>","PeriodicalId":13319,"journal":{"name":"Indian Journal of Palliative Care","volume":"29 3","pages":"256-265"},"PeriodicalIF":1.1,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/e3/f1/IJPC-29-256.PMC10493685.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10244005","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Advancing the Role of Higher Education Institutions to Support Palliative Care Education in Primary Care and Humanitarian Settings within Low- and Middle-Income Countries: Online Workshop Report. 促进高等教育机构在中低收入国家初级保健和人道主义环境中支持姑息治疗教育的作用:在线研讨会报告。
IF 1.1 Q4 HEALTH CARE SCIENCES & SERVICES Pub Date : 2023-07-01 Epub Date: 2023-06-13 DOI: 10.25259/IJPC_45_2023
Teguh Kristian Perdamaian, Michelle McGannan, Liz Grant, David Fearon

The need for palliative care is increasing, especially in low- and middle-income countries (LMICs). Higher education institutions (HEIs) have a role to play in developing a skilled palliative care workforce in LMICs. A workshop was held to discuss this issue, and it was attended by experts from around the world. The workshop highlighted the challenges and opportunities for palliative care education in HEIs for LMIC settings. The participants discussed the importance of a collaborative interprofessional approach and advocacy for the inclusion of palliative care into a wide range of curricula. They also expressed the hope to explore possibilities of networks to continue this discussion and incorporate the wider perspectives from primary care and humanitarian practitioners.

对姑息治疗的需求正在增加,尤其是在中低收入国家。高等教育机构(HEI)在培养LMIC熟练的姑息治疗劳动力方面发挥着作用。为讨论这一问题举行了一次讲习班,来自世界各地的专家出席了讲习班。研讨会强调了在LMIC环境下高等教育机构开展姑息治疗教育的挑战和机遇。与会者讨论了跨专业合作方法和倡导将姑息治疗纳入广泛课程的重要性。他们还表示希望探索网络的可能性,以继续这一讨论,并纳入初级保健和人道主义工作者的更广泛观点。
{"title":"Advancing the Role of Higher Education Institutions to Support Palliative Care Education in Primary Care and Humanitarian Settings within Low- and Middle-Income Countries: Online Workshop Report.","authors":"Teguh Kristian Perdamaian,&nbsp;Michelle McGannan,&nbsp;Liz Grant,&nbsp;David Fearon","doi":"10.25259/IJPC_45_2023","DOIUrl":"10.25259/IJPC_45_2023","url":null,"abstract":"<p><p>The need for palliative care is increasing, especially in low- and middle-income countries (LMICs). Higher education institutions (HEIs) have a role to play in developing a skilled palliative care workforce in LMICs. A workshop was held to discuss this issue, and it was attended by experts from around the world. The workshop highlighted the challenges and opportunities for palliative care education in HEIs for LMIC settings. The participants discussed the importance of a collaborative interprofessional approach and advocacy for the inclusion of palliative care into a wide range of curricula. They also expressed the hope to explore possibilities of networks to continue this discussion and incorporate the wider perspectives from primary care and humanitarian practitioners.</p>","PeriodicalId":13319,"journal":{"name":"Indian Journal of Palliative Care","volume":"29 3","pages":"332-333"},"PeriodicalIF":1.1,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/7b/b6/IJPC-29-332.PMC10493692.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10221631","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Bleeding Control in Advanced Gastric Cancer; Role of Radiotherapy. 晚期癌症出血控制;放射治疗的作用。
IF 1.1 Q4 HEALTH CARE SCIENCES & SERVICES Pub Date : 2023-07-01 Epub Date: 2023-06-12 DOI: 10.25259/IJPC_1_2023
Asifa Andleeb, Kaneez Fatima, Shahida Nasreen, Mushtaq Ahmad Sofi, Arshad Manzoor Najmi, Sumaira Qadri, Farhana Siraj

Objectives: The aim of our study is to see the efficacy of palliative radiotherapy (RT) for bleeding control in patients with advanced gastric cancer (AGC).

Materials and methods: It is a retrospective review based on observations of 74 AGC patients with a median age of 60 years (range 50-82 years) who had active tumour bleeding and were treated with palliative RT. Treatment response was assessed by both subjective symptom relief and objective change in parameters. Objective response to RT was defined by an increase in the median haemoglobin (Hb) level of patients and a decrease in number of packed red blood cell (RBC) units needed by patients after RT.

Results: Response to haemostatic RT was observed in 52 patients out of 74 patients (70.27%). We observed a significant increase in mean Hb level after palliative RT. Pre-RT mean Hb was 6.14 ± 1.01 and post-RT mean Hb was 7.19 ± 1.75 (P < 0.05). Response to RT was also evident in a significant decrease in the number of packed RBC units post-haemostatic RT. The mean number of pre-RT transfused packed RBC units was 8.28 ± 3.76 and post-RT, it was 4.34 ± 2.91 (P < 0.05). The median overall survival was 90 days and the median transfusion-free survival was 40 days.

Conclusion: RT may be an effective treatment option for bleeding control in AGC. In our study, we observed fair and reasonably durable haemostasis. A success rate of 70.24% was documented with clinical palliation, a higher Hb level and fewer transfusions after RT. This modality for bleeding control is more important and reliable in situations where alternative modalities are not feasible.

目的:我们研究的目的是观察姑息性放疗(RT)对晚期癌症(AGC)患者出血控制的疗效。材料和方法:这是一项回顾性综述,基于对74例中位年龄60岁(50-82岁)的AGC患者的观察,这些患者患有活动性肿瘤出血,并接受了姑息性RT治疗。通过主观症状缓解和客观参数变化来评估治疗反应。对RT的客观反应是指患者的中位血红蛋白(Hb)水平增加,RT后患者所需的红细胞(RBC)单位数量减少。结果:74名患者中有52名(70.27%)对止血RT有反应。我们观察到姑息性RT后平均Hb水平显著增加。RT前平均血红蛋白为6.14±1.01,RT后平均血红蛋白为7.19±1.75(P<0.05)。对RT的反应也明显表现为止血RT后填充的红细胞单位数量显著减少。RT前输注的填充红细胞单位的平均数量为8.28±3.76,中位总生存期90天,中位无输血生存期40天。结论:RT可能是控制AGC出血的有效治疗方案。在我们的研究中,我们观察到了公平和合理持久的止血。临床缓解、较高的Hb水平和RT后较少的输血记录了70.24%的成功率。在替代模式不可行的情况下,这种出血控制模式更重要、更可靠。
{"title":"Bleeding Control in Advanced Gastric Cancer; Role of Radiotherapy.","authors":"Asifa Andleeb,&nbsp;Kaneez Fatima,&nbsp;Shahida Nasreen,&nbsp;Mushtaq Ahmad Sofi,&nbsp;Arshad Manzoor Najmi,&nbsp;Sumaira Qadri,&nbsp;Farhana Siraj","doi":"10.25259/IJPC_1_2023","DOIUrl":"10.25259/IJPC_1_2023","url":null,"abstract":"<p><strong>Objectives: </strong>The aim of our study is to see the efficacy of palliative radiotherapy (RT) for bleeding control in patients with advanced gastric cancer (AGC).</p><p><strong>Materials and methods: </strong>It is a retrospective review based on observations of 74 AGC patients with a median age of 60 years (range 50-82 years) who had active tumour bleeding and were treated with palliative RT. Treatment response was assessed by both subjective symptom relief and objective change in parameters. Objective response to RT was defined by an increase in the median haemoglobin (Hb) level of patients and a decrease in number of packed red blood cell (RBC) units needed by patients after RT.</p><p><strong>Results: </strong>Response to haemostatic RT was observed in 52 patients out of 74 patients (70.27%). We observed a significant increase in mean Hb level after palliative RT. Pre-RT mean Hb was 6.14 ± 1.01 and post-RT mean Hb was 7.19 ± 1.75 (<i>P</i> < 0.05). Response to RT was also evident in a significant decrease in the number of packed RBC units post-haemostatic RT. The mean number of pre-RT transfused packed RBC units was 8.28 ± 3.76 and post-RT, it was 4.34 ± 2.91 (P < 0.05). The median overall survival was 90 days and the median transfusion-free survival was 40 days.</p><p><strong>Conclusion: </strong>RT may be an effective treatment option for bleeding control in AGC. In our study, we observed fair and reasonably durable haemostasis. A success rate of 70.24% was documented with clinical palliation, a higher Hb level and fewer transfusions after RT. This modality for bleeding control is more important and reliable in situations where alternative modalities are not feasible.</p>","PeriodicalId":13319,"journal":{"name":"Indian Journal of Palliative Care","volume":"29 3","pages":"279-284"},"PeriodicalIF":1.1,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/54/f1/IJPC-29-279.PMC10493693.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10232131","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Multimodal Properties of Quercetin in Chronic Pain Syndromes. 槲皮素在慢性疼痛综合征中的多模式特性。
IF 1.1 Q4 HEALTH CARE SCIENCES & SERVICES Pub Date : 2023-07-01 Epub Date: 2023-07-11 DOI: 10.25259/IJPC_151_2022
Abhijit Nair
To the Editor, Bioflavonoids are a family of polyphenolic molecules found in a variety of plants and reportedly have significant antioxidant and anti-inflammatory properties. Based on their chemical structure, flavonoids are broadly classified as flavones, isoflavones, flavanones, flavonols, flavan-3-ols (flavanols), and anthocyanins. Despite the difference in their chemical structure, the members of the flavonoid family share the same flavan nucleus. The recent interest in flavonoids for exploring their role in various chronic ailments is probably their antiinflammatory and anti-oxidative properties mediated through various target molecules. Various flavonoid-containing products are available and marketed for topical and oral use. Flavonoids available in natural sources are subject to variable bioavailability when taken orally. To increase its oral bioavailability and water solubility, companies have introduced these formulations as microcapsules, nanoparticles, liposomes, cyclodextrin, and phospholipid inclusion complexes.[1] Quercetin (3,3′,4′,5,7-pentahydroxyflavone) is a flavonol that is the most common flavonoid which has been investigated in various pathologies in human and animal studies [Figure 1]. Quercetin is a member of bioflavonoids and is found in red wine, green tea and onions. It possesses potent free oxygen scavenging, antioxidant and anti-inflammatory properties. As an antioxidant, quercetin scavenges free radicals directly, chelates metal ions and inhibits lipid peroxidation. The antioxidant property demonstrated an increase if the concentration of quercetin used is more. Research has also demonstrated the anti-tumour properties of quercetin by preventing the cell cycle, promoting cell apoptosis and inhibiting angiogenesis.[2-4] Chemotherapy-induced peripheral neuropathy is a distressing condition that is difficult to manage. The use of quercetin provided favourable results in patients with platinum compounds and taxon-induced peripheral neuropathy in induced models and animal studies.[5] Several human and animal studies investigated the role of quercetin supplements in painful arthritis such as osteoarthritis and rheumatoid arthritis successfully. The plausible mechanisms responsible are cyclo-oxygenase 2 inhibition, reduction of tumour necrosis factor α, interleukin 1β and17, and monocyte chemoattractant protein-1 levels.[6] The neuropathic pain associated with diabetic neuropathy is difficult to treat even with a combination of medications. Flavonoid compounds could be the next possible agent which could relieve the suffering of these patients incessantly suffering from excruciating pain. The regular use of flavonoids has been shown to decrease the reactive oxygen species level by increasing the level of antioxidative enzymes such as glutathione peroxidase, reduced glutathione peroxidase and superoxide dismutase, glutathione reductase and catalase in various tissues such as the liver, sciatic nerve and brain of experimental
{"title":"The Multimodal Properties of Quercetin in Chronic Pain Syndromes.","authors":"Abhijit Nair","doi":"10.25259/IJPC_151_2022","DOIUrl":"10.25259/IJPC_151_2022","url":null,"abstract":"To the Editor, Bioflavonoids are a family of polyphenolic molecules found in a variety of plants and reportedly have significant antioxidant and anti-inflammatory properties. Based on their chemical structure, flavonoids are broadly classified as flavones, isoflavones, flavanones, flavonols, flavan-3-ols (flavanols), and anthocyanins. Despite the difference in their chemical structure, the members of the flavonoid family share the same flavan nucleus. The recent interest in flavonoids for exploring their role in various chronic ailments is probably their antiinflammatory and anti-oxidative properties mediated through various target molecules. Various flavonoid-containing products are available and marketed for topical and oral use. Flavonoids available in natural sources are subject to variable bioavailability when taken orally. To increase its oral bioavailability and water solubility, companies have introduced these formulations as microcapsules, nanoparticles, liposomes, cyclodextrin, and phospholipid inclusion complexes.[1] Quercetin (3,3′,4′,5,7-pentahydroxyflavone) is a flavonol that is the most common flavonoid which has been investigated in various pathologies in human and animal studies [Figure 1]. Quercetin is a member of bioflavonoids and is found in red wine, green tea and onions. It possesses potent free oxygen scavenging, antioxidant and anti-inflammatory properties. As an antioxidant, quercetin scavenges free radicals directly, chelates metal ions and inhibits lipid peroxidation. The antioxidant property demonstrated an increase if the concentration of quercetin used is more. Research has also demonstrated the anti-tumour properties of quercetin by preventing the cell cycle, promoting cell apoptosis and inhibiting angiogenesis.[2-4] Chemotherapy-induced peripheral neuropathy is a distressing condition that is difficult to manage. The use of quercetin provided favourable results in patients with platinum compounds and taxon-induced peripheral neuropathy in induced models and animal studies.[5] Several human and animal studies investigated the role of quercetin supplements in painful arthritis such as osteoarthritis and rheumatoid arthritis successfully. The plausible mechanisms responsible are cyclo-oxygenase 2 inhibition, reduction of tumour necrosis factor α, interleukin 1β and17, and monocyte chemoattractant protein-1 levels.[6] The neuropathic pain associated with diabetic neuropathy is difficult to treat even with a combination of medications. Flavonoid compounds could be the next possible agent which could relieve the suffering of these patients incessantly suffering from excruciating pain. The regular use of flavonoids has been shown to decrease the reactive oxygen species level by increasing the level of antioxidative enzymes such as glutathione peroxidase, reduced glutathione peroxidase and superoxide dismutase, glutathione reductase and catalase in various tissues such as the liver, sciatic nerve and brain of experimental ","PeriodicalId":13319,"journal":{"name":"Indian Journal of Palliative Care","volume":"29 3","pages":"334-335"},"PeriodicalIF":1.1,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/6b/cd/IJPC-29-334.PMC10493683.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10244002","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Erratum: Addendum: Looking Ahead: Assured of a Vibrant Indian Association of Palliative Care to Lead the World of Palliative Care. 勘误表:附录:展望未来:确保建立一个充满活力的印度姑息治疗协会,领导姑息治疗世界。
IF 1.1 Q4 HEALTH CARE SCIENCES & SERVICES Pub Date : 2023-07-01 Epub Date: 2023-09-02 DOI: 10.25259/IJPC_149_2022_ER

[This corrects the article DOI: 10.25259/IJPC_149_2022.].

[这更正了文章DOI:10.25259/IJPC_149_2022.]。
{"title":"Erratum: Addendum: Looking Ahead: Assured of a Vibrant Indian Association of Palliative Care to Lead the World of Palliative Care.","authors":"","doi":"10.25259/IJPC_149_2022_ER","DOIUrl":"10.25259/IJPC_149_2022_ER","url":null,"abstract":"<p><p>[This corrects the article DOI: 10.25259/IJPC_149_2022.].</p>","PeriodicalId":13319,"journal":{"name":"Indian Journal of Palliative Care","volume":"29 3","pages":"341"},"PeriodicalIF":1.1,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/30/67/IJPC-29-341.PMC10493688.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10232127","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Dentists Role in Psychological Screening and Management of Head-and-neck Cancer Patients Undergoing Radiotherapy - Narrative Review. 牙医在接受放射治疗的癌症头颈部患者心理筛查和管理中的作用——叙述性评论。
IF 1.1 Q4 HEALTH CARE SCIENCES & SERVICES Pub Date : 2023-07-01 Epub Date: 2023-09-02 DOI: 10.25259/IJPC_47_2023
A Srividya, Astha Chaudhry

Objectives: Head-and-neck cancer management primarily involves surgery and chemoradiotherapy. Recurrent radiotherapy (RT) sessions are often linked to social, physical, and psychological burdens. Oral physicians are part of the palliative care team and play a pivotal role in decimating the physical side effects associated with disease and its treatment. There is a need to familiarise dentists with the psychological aspect of the treatment.

Material and methods: Various libraries were searched from the year 2012 to 2022. A total of nine studies that had head-and-neck RT patients exclusively were included in the study.

Results: Anxiety and depression are patients' most prevalent psychological problems during and after the RT regimen. A few most used psychological screening tools were identified.

Conclusion: Dental professionals are uneducated about the holistic approach to managing RT patients. The current narrative review details the various psychological screening tools and care measures that can be incorporated into the dental setup to help these patients.

目的:癌症头颈部管理主要包括手术和放化疗。复发性放射治疗通常与社会、身体和心理负担有关。口腔医生是姑息治疗团队的一员,在减少与疾病及其治疗相关的身体副作用方面发挥着关键作用。有必要让牙医熟悉这种治疗的心理方面。材料和方法:检索2012年至2022年的各种图书馆。共有9项研究仅对头颈部RT患者进行了研究。结果:在放疗期间和放疗后,焦虑和抑郁是患者最常见的心理问题。确定了一些最常用的心理筛查工具。结论:牙科专业人员对RT患者的整体管理方法缺乏教育。目前的叙述性综述详细介绍了可以纳入牙科设置以帮助这些患者的各种心理筛查工具和护理措施。
{"title":"Dentists Role in Psychological Screening and Management of Head-and-neck Cancer Patients Undergoing Radiotherapy - Narrative Review.","authors":"A Srividya,&nbsp;Astha Chaudhry","doi":"10.25259/IJPC_47_2023","DOIUrl":"10.25259/IJPC_47_2023","url":null,"abstract":"<p><strong>Objectives: </strong>Head-and-neck cancer management primarily involves surgery and chemoradiotherapy. Recurrent radiotherapy (RT) sessions are often linked to social, physical, and psychological burdens. Oral physicians are part of the palliative care team and play a pivotal role in decimating the physical side effects associated with disease and its treatment. There is a need to familiarise dentists with the psychological aspect of the treatment.</p><p><strong>Material and methods: </strong>Various libraries were searched from the year 2012 to 2022. A total of nine studies that had head-and-neck RT patients exclusively were included in the study.</p><p><strong>Results: </strong>Anxiety and depression are patients' most prevalent psychological problems during and after the RT regimen. A few most used psychological screening tools were identified.</p><p><strong>Conclusion: </strong>Dental professionals are uneducated about the holistic approach to managing RT patients. The current narrative review details the various psychological screening tools and care measures that can be incorporated into the dental setup to help these patients.</p>","PeriodicalId":13319,"journal":{"name":"Indian Journal of Palliative Care","volume":"29 3","pages":"250-255"},"PeriodicalIF":1.1,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/7f/89/IJPC-29-250.PMC10493684.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10239164","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Mapping of Influencing Factors in the Decision-Making of End-of-Life Care Patients: A Systematic Scoping Review. 临终关怀患者决策中影响因素的映射:一项系统范围界定综述。
IF 1.1 Q4 HEALTH CARE SCIENCES & SERVICES Pub Date : 2023-07-01 Epub Date: 2023-07-05 DOI: 10.25259/IJPC_292_2022
Mauricio de Almeida Pereira da Silva, Carla Corradi-Perini

Decisions in end-of-life care are influenced by several factors, many of which are not identified by the decision maker. These influencing factors modify important decisions in this scenario, such as in decisions to adapt to therapeutic support. This presented scoping review aims to map the factors that influence end-of-life care decisions for adult and older adult patients, by a scoping review. The review was carried out in 19 databases, with the keyword 'clinical decision-making' AND 'terminal care' OR 'end-of-life care' and its analogues, including publications from 2017 to 2022. The study was conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses for Scoping Reviews. The search resulted in 3474 publications, where the presence of influencing factors in end-of-life decision-making for adults and the elderly was applied as a selection criterion. Fifty-four (54) of them were selected, which means 1.5% of all the results. Among the selected publications, 89 influencing factors were found, distributed in 54 (60.6%) factors related to the health team, 18 (20.2%) to patients, 10 (11.2%) related to family or surrogates and 7 (7.8%) factors related to the decision environment. In conclusion, we note that the decision-making in end-of-life care is complex, mainly because there is an interaction of different characters (health team, patient, family, or surrogates) with a plurality of influencing factors, associated with an environment of uncertainty and that result in a critical outcome, with a great repercussion for the end of life, making it imperative the recognition of these factors for more competent and safe decision-making.

临终关怀的决策受到几个因素的影响,其中许多因素没有由决策者确定。这些影响因素改变了这种情况下的重要决策,例如适应治疗支持的决策。本次范围界定审查旨在通过范围界定审查,绘制影响成年和老年患者临终关怀决策的因素图。这项审查在19个数据库中进行,关键词为“临床决策”和“临终关怀”或“临终护理”及其类似物,包括2017年至2022年的出版物。本研究根据系统评价的首选报告项目和范围界定评价的荟萃分析进行。搜索结果得到了3474份出版物,其中将成年人和老年人临终决策中存在的影响因素作为选择标准。其中五十四(54)人被选中,这意味着占所有结果的1.5%。在选定的出版物中,发现了89个影响因素,分布在54个(60.6%)与健康团队有关的因素中,18个(20.2%)与患者有关,10个(11.2%)与家庭或代孕者有关,7个(7.8%)与决策环境有关。总之,我们注意到,临终关怀的决策是复杂的,主要是因为不同特征(健康团队、患者、家人或代理人)与多种影响因素之间存在相互作用,这些因素与不确定性环境有关,并导致关键结果,对临终产生巨大影响,使得必须认识到这些因素,以便做出更有能力和更安全的决策。
{"title":"The Mapping of Influencing Factors in the Decision-Making of End-of-Life Care Patients: A Systematic Scoping Review.","authors":"Mauricio de Almeida Pereira da Silva, Carla Corradi-Perini","doi":"10.25259/IJPC_292_2022","DOIUrl":"10.25259/IJPC_292_2022","url":null,"abstract":"<p><p>Decisions in end-of-life care are influenced by several factors, many of which are not identified by the decision maker. These influencing factors modify important decisions in this scenario, such as in decisions to adapt to therapeutic support. This presented scoping review aims to map the factors that influence end-of-life care decisions for adult and older adult patients, by a scoping review. The review was carried out in 19 databases, with the keyword 'clinical decision-making' AND 'terminal care' OR 'end-of-life care' and its analogues, including publications from 2017 to 2022. The study was conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses for Scoping Reviews. The search resulted in 3474 publications, where the presence of influencing factors in end-of-life decision-making for adults and the elderly was applied as a selection criterion. Fifty-four (54) of them were selected, which means 1.5% of all the results. Among the selected publications, 89 influencing factors were found, distributed in 54 (60.6%) factors related to the health team, 18 (20.2%) to patients, 10 (11.2%) related to family or surrogates and 7 (7.8%) factors related to the decision environment. In conclusion, we note that the decision-making in end-of-life care is complex, mainly because there is an interaction of different characters (health team, patient, family, or surrogates) with a plurality of influencing factors, associated with an environment of uncertainty and that result in a critical outcome, with a great repercussion for the end of life, making it imperative the recognition of these factors for more competent and safe decision-making.</p>","PeriodicalId":13319,"journal":{"name":"Indian Journal of Palliative Care","volume":"29 3","pages":"234-242"},"PeriodicalIF":1.1,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/65/6c/IJPC-29-234.PMC10493695.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10244000","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Literature Review of Nurses Challenges and Barriers in Assisting Patients and Families Facing Breaking Bad News. 护士在帮助面临突发新闻的患者和家庭方面面临的挑战和障碍的文献综述。
IF 1.1 Q4 HEALTH CARE SCIENCES & SERVICES Pub Date : 2023-07-01 Epub Date: 2023-09-02 DOI: 10.25259/IJPC_128_2023
Surya Wahyuni, Made Satya Nugraha Gautama, Tiur Yulianta Simamora

Objectives: Breaking bad news (BBN) is a challenging task for healthcare professionals, including nurses. The manner in which bad news is delivered can have a significant impact on patients and their families, either positive or negative. Understanding the roles, methods, obstacles, and challenges that nurses face in the process of delivering bad news is crucial for improving the quality of the delivery process.

Material and methods: This narrative review synthesises related studies. The search was conducted through PubMed, Scopus, ScienceDirect and Sage, with no restriction on publication year. The main keywords were 'nurse's challenge', 'nurse's barrier', 'bad news', 'breaking bad news', and 'communicating bad news.' A total of 12 articles were selected from 1075 articles.

Results: Nurses play a key role in BBN before, during and after the process. Their activities include preparing patients to receive bad news, supporting patients and families when doctors deliver bad news and clarifying information obtained by patients and families regarding the prognosis of their illness. Nurses should possess skills such as building interpersonal relationships, therapeutic communication and providing emotional care for patients and their families. The main challenges and barriers for nurses in implementing BBN are due to a lack of skills and unpreparedness for patient and family reactions. After BBN, the most reported roles of nurses were supporting patients and families and helping them understand the information received from doctors. It is essential for nurses to have the necessary skills and preparedness to effectively deliver bad news to patients and their families.

Conclusion: Nurses play a crucial role in delivering bad news to patients and their families. They should be equipped with the necessary skills to effectively communicate with patients and their families during this difficult time. Further training for nurses in therapeutic communication, emotional care for patients and their families, and building interpersonal relationships could help to improve the quality of the delivery process.

目标:突发坏消息(BBN)对包括护士在内的医疗专业人员来说是一项具有挑战性的任务。坏消息的传递方式可能会对患者及其家人产生重大影响,无论是积极的还是消极的。了解护士在传递坏消息过程中面临的角色、方法、障碍和挑战,对于提高传递过程的质量至关重要。材料和方法:这篇叙述性综述综合了相关研究。搜索通过PubMed、Scopus、ScienceDirect和Sage进行,不受出版年份限制。主要关键词是“护士的挑战”、“护士的障碍”、“坏消息”、“突发坏消息”和“传达坏消息”共从1075篇文章中选出12篇。结果:护士在BBN实施前、实施中和实施后都发挥着关键作用。他们的活动包括让患者做好接收坏消息的准备,在医生发出坏消息时为患者和家属提供支持,并澄清患者和家属获得的有关其疾病预后的信息。护士应具备建立人际关系、治疗沟通以及为患者及其家人提供情感护理等技能。护士在实施BBN时面临的主要挑战和障碍是由于缺乏技能以及对患者和家庭反应没有做好准备。BBN之后,据报道护士的角色最多的是支持患者和家属,帮助他们了解从医生那里收到的信息。护士必须具备必要的技能和准备,才能有效地向患者及其家人传递坏消息。结论:护士在向患者及其家属传递坏消息方面发挥着至关重要的作用。他们应该具备在这段困难时期与患者及其家人有效沟通的必要技能。对护士进行进一步的治疗沟通、患者及其家人的情感护理和建立人际关系方面的培训,有助于提高分娩过程的质量。
{"title":"A Literature Review of Nurses Challenges and Barriers in Assisting Patients and Families Facing Breaking Bad News.","authors":"Surya Wahyuni,&nbsp;Made Satya Nugraha Gautama,&nbsp;Tiur Yulianta Simamora","doi":"10.25259/IJPC_128_2023","DOIUrl":"10.25259/IJPC_128_2023","url":null,"abstract":"<p><strong>Objectives: </strong>Breaking bad news (BBN) is a challenging task for healthcare professionals, including nurses. The manner in which bad news is delivered can have a significant impact on patients and their families, either positive or negative. Understanding the roles, methods, obstacles, and challenges that nurses face in the process of delivering bad news is crucial for improving the quality of the delivery process.</p><p><strong>Material and methods: </strong>This narrative review synthesises related studies. The search was conducted through PubMed, Scopus, ScienceDirect and Sage, with no restriction on publication year. The main keywords were 'nurse's challenge', 'nurse's barrier', 'bad news', 'breaking bad news', and 'communicating bad news.' A total of 12 articles were selected from 1075 articles.</p><p><strong>Results: </strong>Nurses play a key role in BBN before, during and after the process. Their activities include preparing patients to receive bad news, supporting patients and families when doctors deliver bad news and clarifying information obtained by patients and families regarding the prognosis of their illness. Nurses should possess skills such as building interpersonal relationships, therapeutic communication and providing emotional care for patients and their families. The main challenges and barriers for nurses in implementing BBN are due to a lack of skills and unpreparedness for patient and family reactions. After BBN, the most reported roles of nurses were supporting patients and families and helping them understand the information received from doctors. It is essential for nurses to have the necessary skills and preparedness to effectively deliver bad news to patients and their families.</p><p><strong>Conclusion: </strong>Nurses play a crucial role in delivering bad news to patients and their families. They should be equipped with the necessary skills to effectively communicate with patients and their families during this difficult time. Further training for nurses in therapeutic communication, emotional care for patients and their families, and building interpersonal relationships could help to improve the quality of the delivery process.</p>","PeriodicalId":13319,"journal":{"name":"Indian Journal of Palliative Care","volume":"29 3","pages":"243-249"},"PeriodicalIF":1.1,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/09/26/IJPC-29-243.PMC10493690.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10240638","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Indian Journal of Palliative Care
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1